August 3, 2020
Consumer genomic company Ancestry, which got its start in providing testing for family history, is launching a new product which features next-generation sequencing. The new product aims to help customers gain insights into their health and risk factors.
Called “AncestryHealth powered by Next Generation Sequencing,” the tool can screen for genes associated with breast cancer, heart disease,...
July 31, 2020
Google has posted an update on Exposure Notifications – their system-level framework for COVID-19 contact tracing developed in tandem with Apple – revealing that the tools have been incorporated into digital contact-tracing apps launched in 16 countries.
Further, 20 U.S. states and territories are "exploring apps" based on the system, according to Google, the first set of which are expected to go...
July 30, 2020
D2C wellness and telehealth startup Hims & Hers is looking to cut down the time between medication orders and delivery for certain customers.
Thanks to a newly announced partnership, patients receiving virtual primary care services through Hims & Hers may choose to select Alto as their preferred pharmacy for prescription deliveries. They will have their orders fulfilled automatically ...
Credit: Liva health coach
July 30, 2020
IRELAND’S CONTACT TRACING APP
In the two weeks since Ireland’s Covid Tracker app was launched, it has been reported that 91 users have received a “close contact exposure alert”.
The app invites users to give permission for the collection of some data, including whether a user receives a close contact alert, making it one of the first to supply data showing how many people have received alerts. ...
July 28, 2020
A leading healthcare operator in the United Arab Emirates (UAE) has recruited the San Jose-headquartered Automation Anywhere to provide artificial intelligence (AI)-powered software bots to its systems. Its aim is to “improve patient care and automate end-to-end business processes” during the ongoing COVID-19 pandemic.
Saudi German Hospitals (SGH) UAE – which runs three tertiary care operating...
July 28, 2020
Withings, a maker of several consumer and B2B connected health devices once owned by Nokia, has announced the close of a $60 million Series B round. The raise was co-headed by Gilde Healthcare, Idinvest Partners and Bpifrance. BNP Paribas Développement, ODDO BHF Private Equity and Adelie Capital also participated.
The company has also appointed a new global medical advisory board that includes Dr...
July 27, 2020
On Friday evening, the FDA reissued an emergency use authorization (EUA) for LabCorp's COVID-19 RE-PCR Test that now allows for testing among those without any symptoms of COVID-19.
The agency also expanded the indication to allow for pooled sample testing – a technique of combining multiple samples into a single test, and then following up with individual tests should the group be positive. The...
July 27, 2020
About the author: Roman Giverts is founder and CEO of VuMedi, a video education platform for doctors. The platform hosts more than 30,000 videos from medical institutions including Cleveland Clinic, UCSF, Stanford, Columbia and others.
COVID-19 has accelerated our reliance on digital platforms for news and information. As businesses and communities shut down over the last three months in the name...
July 24, 2020
Abbott has received FDA approval for a neuromodulation system-controller app that runs on iOS devices, the company announced Thursday.
Compatible with Abbott's broader NeuroSphere Digital Care platform, the Patient Controller app replaces the separate device patients use to adjust the company's neuromodulation products. These include the Infinity DBS System for Parkinson's disease or essential...
July 23, 2020
Consumer wellness and telehealth company Hims could be the next to throw its hat into the public markets.
According to a report from Reuters, the startup is weighing a potential sale to an unnamed special purpose acquisition company (SPAC) – a "blank-check company" that uses the proceeds of an IPO to acquire or merge another business.
The deal would value Hims at over $1 billion, Reuters' sources...